Close search filters
Changing filters will change the listed Success Criteria and Techniques
Category
Topic
Search results (19)
Article
Express Scripts in 2023: Supporting clients, patients, and health plans
December 19, 2023
Over the last 12 months, Express Scripts has rolled out numerous groundbreaking programs and projects. Learn about some of the most notable advancements and innovations of 2023.
Video
Biosimilars 101
October 17, 2022
To help clients prepare for the wave of biosimilars on the horizon, we answer some basic questions about these potentially game-changing medications.
Press Release
Express Scripts Comments on FTC’s Reckless Insulin Action
September 20, 2024
Article
How partnership drives improved affordability and safety at the pharmacy
July 15, 2022
Express Scripts’ collaboration with GoodRx expands savings at the pharmacy counter while improving adherence, safety and overall health outcomes.
Article
Preparing the market for the evolving biosimilar landscape
December 19, 2023
With more biosimilars and the first major influx of interchangeable inflammatory biosimilars coming to market, proactive education and outreach will be crucial for successful conversions to low-cost o...
Press Release
Express Scripts Adds Three Biosimilars to Largest Formulary to Promote Competition and Advance Affordability, Choices for Patients
July 10, 2023
Press Release
Express Scripts launches new initiative to expand rural health care access through partnerships with independent pharmacies
April 20, 2023
Express Scripts announced key efforts to expand access to health care in rural communities through partnerships with independent pharmacies across the U.S.
Article
What to look for in the upcoming gene therapy pipeline
April 20, 2023
As the gene therapy landscape continues to evolve, plan sponsors should familiarize themselves with the tools and strategies necessary to navigate the future of these game-changing treatments.